Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Potential new indications and future studies.

Sudano I, Noll G, Luscher TF.

EuroIntervention. 2013 May;9 Suppl R:R155-60. doi: 10.4244/EIJV9SRA26. Review.

PMID:
23732149
2.

Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.

Hering D, Esler MD, Schlaich MP.

EuroIntervention. 2013 May;9 Suppl R:R127-35. doi: 10.4244/EIJV9SRA22. Review.

PMID:
23732145
3.

Renal denervation: expanding the indication.

Daemen J, Mahfoud F.

EuroIntervention. 2013 May;9 Suppl R:R101-4. doi: 10.4244/EIJV9SRA17. No abstract available.

PMID:
23732139
4.

Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.

McArdle MJ, deGoma EM, Cohen DL, Townsend RR, Wilensky RL, Giri J.

J Am Heart Assoc. 2015 Mar 23;4(3):e001415. doi: 10.1161/JAHA.114.001415. Review. No abstract available.

5.

Expanding the indication spectrum: renal denervation in diabetes.

Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka PA, Cremers B, Böhm M.

EuroIntervention. 2013 May;9 Suppl R:R117-21. doi: 10.4244/EIJV9SRA20. Review.

PMID:
23732142
6.

Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.

Kjeldsen SE, Os I, Mahfoud F.

EuroIntervention. 2013 May;9 Suppl R:R7-9. doi: 10.4244/EIJV9SRA1. No abstract available.

PMID:
23732159
7.

Renal sympathetic denervation: applications in hypertension and beyond.

Böhm M, Linz D, Urban D, Mahfoud F, Ukena C.

Nat Rev Cardiol. 2013 Aug;10(8):465-76. doi: 10.1038/nrcardio.2013.89. Epub 2013 Jun 18. Review.

PMID:
23774592
8.

Follow-up, study design and outcome parameters.

Volpe M, Battistoni A, Tocci G.

EuroIntervention. 2013 May;9 Suppl R:R96-100. doi: 10.4244/EIJV9SRA16.

PMID:
23732163
9.

Beyond Blood Pressure: Percutaneous Renal Denervation for the Management of Sympathetic Hyperactivity and Associated Disease States.

McArdle MJ, deGoma EM, Cohen DL, Townsend RR, Wilensky RL, Giri J.

J Am Heart Assoc. 2016 Jan 4;5(3):e001415. doi: 10.1161/JAHA.114.001415. Review. No abstract available.

10.

Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.

Ammar S, Ladich E, Steigerwald K, Deisenhofer I, Joner M.

EuroIntervention. 2013 May;9 Suppl R:R89-95. doi: 10.4244/EIJV9SRA15. Review.

PMID:
23732162
11.

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.

Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M.

Circulation. 2011 May 10;123(18):1940-6. doi: 10.1161/CIRCULATIONAHA.110.991869. Epub 2011 Apr 25.

12.

Obstructive sleep apnoea, resistant hypertension and renal denervation.

Witkowski A, Kadziela J.

EuroIntervention. 2013 May;9 Suppl R:R105-9. doi: 10.4244/EIJV9SRA18. Review.

PMID:
23732140
13.

Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure.

Böhm M, Ewen S, Linz D, Reil JC, Schirmer SH, Ukena C, Mahfoud F.

EuroIntervention. 2013 May;9 Suppl R:R122-6. doi: 10.4244/EIJV9SRA21. Review.

PMID:
23732144
14.

Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.

Prochnau D, Figulla HR, Surber R.

Expert Rev Med Devices. 2013 Mar;10(2):247-56. doi: 10.1586/erd.13.1. Review.

PMID:
23480093
15.

Renal denervation: a plea for wisdom.

Lantelme P, Courand PY, Pathak A.

Arch Cardiovasc Dis. 2013 Mar;106(3):121-3. doi: 10.1016/j.acvd.2013.02.002. Epub 2013 Mar 27. No abstract available.

16.

Resistant hypertension: is renal denervation the current treatment of choice?

Reddi AS.

Clin Exp Hypertens. 2014;36(8):525-30. doi: 10.3109/10641963.2014.881846. Epub 2014 Mar 28. Review.

PMID:
24678737
17.

Renal denervation for resistant hypertension and beyond.

Laffin LJ, Bakris GL.

Adv Chronic Kidney Dis. 2015 Mar;22(2):133-9. doi: 10.1053/j.ackd.2014.11.005. Review.

PMID:
25704350
18.

Response and non-response to renal denervation: who is the ideal candidate?

Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F.

EuroIntervention. 2013 May;9 Suppl R:R54-7. doi: DOI: 10.4244/EIJV9SRA10. Review.

PMID:
23732156
19.

Renal denervation in the treatment of resistant arterial hypertension.

Lambert T, Schützenberger W, Steinwender C.

Wien Med Wochenschr. 2014 Dec;164(23-24):515-8. doi: 10.1007/s10354-014-0330-9. Epub 2014 Nov 14.

PMID:
25394989
20.

Renal denervation and heart failure.

Böhm M, Ewen S, Kindermann I, Linz D, Ukena C, Mahfoud F.

Eur J Heart Fail. 2014 Jun;16(6):608-13. doi: 10.1002/ejhf.83. Epub 2014 Mar 18. Review.

Supplemental Content

Support Center